Introduction
============

Aortic aneurysm (AA), defined as an enlargement of the aorta to greater than 1.5 times normal size ([@b1-etm-0-0-6391]) is usually asymptotic, but when rupture occurs, this may lead to internal bleeding, shock and mortality, unless treated immediately ([@b2-etm-0-0-6391]). Although AA is rather rare with an incidence of approximately 10 per 100,000 for thoracic aortic aneurysm (ΤΑΑ) ([@b3-etm-0-0-6391]) and 55--298 per 100,000 for abdominal aortic aneurysm (AAA) ([@b4-etm-0-0-6391]), the burden of the disease is heavy and may be underestimated ([@b5-etm-0-0-6391]--[@b7-etm-0-0-6391]). Given the high total mortality estimated at 80--100% for ruptured AA ([@b8-etm-0-0-6391],[@b9-etm-0-0-6391]), the best way to reduce the overall mortality of the disease may be to detect and treat it prior to rupture. In fact, many predictors or predictive models of mortality risk in AA patients have been reported ([@b10-etm-0-0-6391]--[@b14-etm-0-0-6391]), but further validation is required. Herein, we focused on AA patients in intensive care unit (ICU) and investigated the predictive value of serum anion gap on ICU mortality, a routine clinical indicator which has been reported to be associated with mortality of several diseases ([@b15-etm-0-0-6391]--[@b18-etm-0-0-6391]). Although a few studies have reported the association between anion gap with ICU mortality ([@b19-etm-0-0-6391],[@b20-etm-0-0-6391]), to the best of our knowledge, no research to date has specially investigated the association in AA patients admitted to ICU. Considering the extremely low incidence of AA, we performed a retrospective analysis on a large publicly accessible clinical database, hoping to clarify the association between anion gap and ICU mortality.

Patients and methods
====================

### Database introduction

The retrospective analysis was conducted using data from the Medical Information Mart for Intensive Care III (MIMIC-III) database (version 1.4) ([@b21-etm-0-0-6391]), a large and freely-available database comprising deidentified health-related data of patients admitted to ICU of the Beth Israel Deaconess Medical Center between 2001 and 2012. The database contains information including demographics, laboratory test results, and clinical outcomes. The access of the database was approved by the institutional review boards of both Beth Israel Deaconess Medical Center and Massachusetts Institute of Technology Affiliates.

### Study design

Adult patients (age ≥18 years old) with first hospital admission and first ICU admission were considered for inclusion. AA patients were selected according to their primary diagnoses based on ICD-9 codes (4412--4415, and 4419), and patients with a length of ICU stay less than 24 h or a missing value of admission serum anion gap were excluded.

We used the codes from the MIMIC Code Repository (<https://github.com/MIT-LCP/mimic-code>) ([@b22-etm-0-0-6391]) to extract data from the database. Variables were extracted or calculated including admission serum anion gap (item ID=50868 in the database, detected within 24 h after ICU admission), severity scores including SOFA ([@b23-etm-0-0-6391]) and APACHE III ([@b24-etm-0-0-6391]), sepsis defined by ICD-9 codes (99592 and 78552), sepsis defined by Angus criteria ([@b25-etm-0-0-6391]) and comorbidities ([@b26-etm-0-0-6391]) based on ICD-9 codes. For patients \>89 years old, date of birth had been shifted to exactly 300 years before by the database to obscure age, therefore this was corrected (age-300+89) prior to analysis. No informed consent was required as the data were anonymized.

### Outcomes

ICU mortality was chosen as the primary study outcome before analysis. Hospital mortality, length of ICU stay, and length of hospital stay were also calculated. Although only patients of first hospital admission were included, it is possible for a patient to be transferred from one type of ICU to another. In this case, the primary outcome ICU mortality and length of ICU stay were determined only by the first ICU stay. Apart from statistical description, only the primary outcome was analyzed further.

### Statistical analysis

Data are presented as median and interquartile range (IQR) for continuous variables and numbers and percentages for categorical variables. Kruskal Wallis and Chi-square (or Fisher\'s exact) tests were used to analyze continuous and categorical variables, respectively. Relationship between admission serum anion gap and ICU mortality was explored using the smoothing plot with an adjustment for potential confounders (age, sex, and SOFA were selected before analysis). A two-piecewise linear regression model was applied to examine the threshold effect of admission serum anion gap on ICU mortality according to the smoothing plot. Factors associated with ICU mortality were evaluated by univariate logistic analysis and variables that showed statistically significant association with ICU mortality in the univariate analysis (P\<0.05) were included in the multivariable logistic regression model, but variables with missing values \>10% were excluded. Considering that there was a certain overlap in the two severity scores and sepsis based on different criteria, we only selected SOFA and sepsis based on ICD-9 codes to be enrolled in the multivariable analysis if the variables were statistically significant in the univariate analysis. If a nonlinear relationship and a threshold effect were found in the previous analysis, then the subjects were stratified according to the threshold level and the logistic analysis was repeated. Receiver operating characteristic (ROC) curves were constructed and the area under the ROC curve (AUC) was calculated to evaluate the predictions. Consistency of the results in several subgroups was also explored using logistic regression models. To maximize statistical power and minimize potential bias that may have occurred if variables with missing values \>10% were excluded from analyses, missing values of continuous and categorical covariates in outcome analysis were handled using multiple imputation with 5 imputed data sets, and results were pooled according to Rubin\'s rules ([@b27-etm-0-0-6391]). A multivariable analysis was also performed after excluding patients with ruptured AA. A P-value of \<0.05 was considered statistically significant. Empower(R) ([www.empowerstats.com](www.empowerstats.com); X&Y solutions, Inc., Boston, MA, USA) and R software, version 3.4.3 (<http://www.r-project.org>) were used for all statistical analyses.

Results
=======

### Population and baseline characteristics

A total of 273 patients were included and analyzed ([Fig. 1](#f1-etm-0-0-6391){ref-type="fig"}). The number of missing values for all variables are presented in [Table I](#tI-etm-0-0-6391){ref-type="table"}. As shown in [Table II](#tII-etm-0-0-6391){ref-type="table"}, The median age of the study subjects was 73.16 years (IQR 65.14--80.06 years) and 154 of the 273 cases (56.41%) were male. The median admission serum anion gap was 13.00 mEq/l (IQR 11.00--15.00 mEq/l) with a median SOFA score of 5 (IQR 4--8). Among them, 8 (2.93%) patients were diagnosed as sepsis based on ICD-9 codes and 227 (83.15%) patients required ventilation. The five most common comorbidities were chronic pulmonary disease (28.94%), fluid and electrolyte disorders (27.84%), peripheral vascular disorder (26.01%), coagulopathy (17.22%), and uncomplicated diabetes (15.02%).

### Survival status of the population

The ICU mortality was 8.79% with 24 non-survivors and 249 survivors and the hospital mortality was 9.89% (27/273). The median length of ICU stay and hospital stay was 3.23 (IQR 1.90--9.22) and 9.32 (IQR 6.25--16.92) days, respectively. As shown in [Table II](#tII-etm-0-0-6391){ref-type="table"}, non-survivors had significantly higher SOFA and APACHE (P\<0.001). Furthermore, they were more likely to suffer from sepsis and require renal replacement therapy in first day. A significantly lower admission serum anion gap was observed in survivors (P\<0.001).

### Association between serum anion gap on admission and ICU mortality

Further analysis indicated that admission serum anion gap increased with increased ICU mortality when patients were stratified according to serum anion gap levels on admission ([Table III](#tIII-etm-0-0-6391){ref-type="table"}), but no significant nonlinear relationship or threshold effect between them were observed ([Fig. 2](#f2-etm-0-0-6391){ref-type="fig"} and [Table IV](#tIV-etm-0-0-6391){ref-type="table"}). After adjustment for potential confounders according to the univariate analysis (presented in [Table V](#tV-etm-0-0-6391){ref-type="table"}), admission serum anion gap was found to be significantly associated with ICU mortality \[odds ratio (OR) 1.38 per 1 mEq/l increase, 95% confidence interval (CI), 1.08--1.76; P=0.0088\] ([Table VI](#tVI-etm-0-0-6391){ref-type="table"}). As shown in [Fig. 3](#f3-etm-0-0-6391){ref-type="fig"}, AUC of serum anion gap for discrimination of survivors and non-survivors was 0.8513 (95% CI, 0.7698--0.9328), which suggested its potentially efficient predictive role in ICU mortality for AA patients.

### Subgroup analysis

The results of the stratified and interaction analyses of the association between admission serum anion gap and ICU mortality are presented in [Fig. 4](#f4-etm-0-0-6391){ref-type="fig"} and [Table VII](#tVII-etm-0-0-6391){ref-type="table"}. The association appeared to be similar when compared with the results of the multivariable analysis shown in [Table VI](#tVI-etm-0-0-6391){ref-type="table"}. A significant interaction (P\<0.05) was found among subgroups of tertile of hemoglobin.

### Sensitive analysis

The imputation of missing variables did not affect the results ([Table VIII](#tVII-etm-0-0-6391){ref-type="table"}), which were virtually unchanged (\<10%) after excluding ruptured AA patients ([Table IX](#tIX-etm-0-0-6391){ref-type="table"} and [X](#tX-etm-0-0-6391){ref-type="table"}).

Discussion
==========

The present study examined for the first time the predictive value of serum anion gap on ICU mortality in AA patients, and the results suggested that the risk of ICU mortality may increase by 38% per 1 mEq/l increase in admission serum anion gap.

Many studies have explored the relationship between anion gap and clinical outcomes of critically ill patients. In fact, as early as 1987, Shackleton *et al* ([@b14-etm-0-0-6391]) noted that an elevation of the unmeasured anion gap was significantly and independently associated with mortality for ruptured AAA patients. Grist *and Thomas* ([@b28-etm-0-0-6391]) reported that anion gap is a risk factor in long-term extracorporeal support. Kim *et al* ([@b19-etm-0-0-6391]) found a similar association in a pediatric ICU. However, Rocktaeschel *et al* ([@b29-etm-0-0-6391]) concluded that unmeasured anions, irrespective of the calculated methods, were not practical predictors of hospital mortality in critically ill patients. In addition, the use of anion gap for risk stratification in critically ill patients is not supported for the significant statistical heterogeneity according to a recent systematic review and meta-analysis conducted by Glasmacher *and Stones* ([@b20-etm-0-0-6391]). Considering the urgent need for a practical and useful predictive model of AA ([@b30-etm-0-0-6391]), which is notorious for high mortality, it is essential to keep exploring predictors of clinical outcomes for AA patients. As anion gap is routinely determined in all patients admitted to ICU and there is no extra cost for this potential beneficial test, a study that specifically focused on AA patients was necessary, given the extremely low incidence of AA. The results of our study validated the association between serum anion gap and ICU mortality, which was in accordance with most previous studies ([@b20-etm-0-0-6391]), suggesting that serum anion gap may serve as a mortality predictor for AA patients in ICU. The AUC of anion gap was similar to the SOFA and APACHE III values in our study. As anion gap is a traditional tool used to assess acid-base status, most previous studies usually attribute the association to acid-base disorders, which contribute significantly to morbidity and mortality in critically ill patients ([@b31-etm-0-0-6391]). Taylor *et al* ([@b32-etm-0-0-6391]) reported that anion gap is independently associated with higher blood pressure, which is associated with negative outcomes for AA patients ([@b33-etm-0-0-6391]), thus the underlying mechanism requires further research.

Several limitations of our study should be noted. First, although hypoalbuminemia could affect its interpretation, anion gap was not corrected for serum albumin level in our study as most subjects analyzed lacked albumin records. Second, although attempts were taken to control bias and confounders, many other known or unknown factors may still exist and have contributed to bias. For example, although we took into consideration fluid and electrolyte disorders (identified by ICD-9 codes) as a potential confounder, the quantities and types of intravenous infusion fluids before ICU admission may have affected the value of serum anion gap on ICU admission. Other potential confounders including smoking status, diameters of the aorta, and surgical procedures were not considered in the study. In addition, given the observational nature of our study, it is not possible to conclude that the relationship between admission serum anion gap and ICU mortality reflects cause and effect.

In summary, the present retrospective observational study provided confirmation of the association between serum anion gap on admission and ICU mortality of AA patients. However, further prospective clinical studies are still required, particularly to explore the potential value of anion gap in improving various predictive models for ICU outcomes.
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![Flow chart of the study population. ICU, intensive care unit; ICD-9, International Classification of Diseases, 9th Revision.](etm-16-03-1766-g00){#f1-etm-0-0-6391}

![Non-linear curve fitting of the relationship between anion gap and ICU mortality. Adjusted for age, SOFA and sex. ICU, intensive care unit.](etm-16-03-1766-g01){#f2-etm-0-0-6391}

![ROC curves of anion gap in the prediction of ICU mortality. The gray line represents the reference line. ROC curves, Receiver operating characteristic curves; ICU, intensive care unit; AUC, area under the ROC curves; APACHE III, Acute Physiology and Chronic Health Evaluation III; SOFA, Sepsis-related Organ Failure Assessment.](etm-16-03-1766-g02){#f3-etm-0-0-6391}

![Subgroup analysis of association between admission serum anion gap and ICU mortality. Horizontal lines represent 95% confidence intervals. P-values for interactions were calculated with the use of likelihood-ratio tests comparing logistic regression models (after adjusting for age, sex and SOFA) with and without cross-product terms for each level of baseline stratifying variables, with admission serum anion gap as an explanatory variable. Detailed data are shown in [Table VII](#tVII-etm-0-0-6391){ref-type="table"}. ICU, intensive care unit; OR, odds ratio; CI, confidence interval.](etm-16-03-1766-g03){#f4-etm-0-0-6391}

###### 

Numbers of subjects with missing values.

  Variables                   Numbers of subjects with specific missing value
  --------------------------- -------------------------------------------------
  Hemoglobin                  1
  Lactate                     61
  Platelet                    1
  PTT                         11
  INR                         12
  PT                          12
  WBC                         2
  Urine output in first day   4
  Heartrate                   2
  Systolic pressure           3
  Diastolic pressure          3
  Respiratory rate            2
  Temperature                 23
  SpO2                        2

PTT, partial thromboplastin time; INR, international normalised ratio; PT, prothrombin time; WBC, white blood cell.

###### 

Clinical characteristics of study subjects.

  Parameter                                         All (n=273)                   Survivors (n=249)               Non-survivors (n=24)        P-value
  ------------------------------------------------- ----------------------------- ------------------------------- --------------------------- ---------
  Age (years)                                       73.16 (65.14--80.06)          72.58 (64.59--79.76)            77.74 (72.11--82.80)        0.009
  Sex (male), n (%)                                 154 (56.41%)                  143 (57.43%)                    11 (45.83%)                 0.274
  Type of aortic aneurysm                                                                                                                     0.002
    Thoracic aneurysm without mention of rupture    109 (39.93%)                  104 (41.77%)                    5 (20.83%)                  
    Abdominal aneurysm (ruptured)                   48 (17.58%)                   37 (14.86%)                     11 (45.83%)                 
    Abdominal aneurysm without mention of rupture   116 (42.49%)                  108 (43.37%)                    8 (33.33%)                  
  Anion gap (mEq/l)                                 13.00 (11.00--15.00)          13.00 (11.00--15.00)            17.50 (15.75--22.50)        \<0.001
  ICU mortality                                     24 (8.79%)                                                                                
  Hospital mortality                                27 (9.89%)                    3 (1.20%)                       24 (100.00%)                \<0.001
  ICU length of stay (days)                         3.23 (1.90--9.22)             3.16 (1.81--8.99)               10.88 (2.58--15.06)         0.008
  Hospital length of stay (days)                    9.32 (6.25--16.92)            9.30 (6.39--17.04)              10.84 (4.62--16.38)         0.317
  Severity score                                                                                                                              
    SOFA                                            5.00 (4.00--8.00)             5.00 (3.00--7.00)               9.00 (8.00--11.25)          \<0.001
    APACHE III                                      39.00 (29.00--54.00)          38.00 (28.00--50.00)            70.00 (52.00--85.75)        \<0.001
  Vital signs                                                                                                                                 
    Heartrate (bpm)                                 80.60 (73.07--88.98)          79.86 (72.69--87.77)            88.60 (83.54--95.75)        0.002
    Systolic pressure (mmHg)                        113.98 (106.58--124.29)       114.80 (106.79--124.01)         109.67 (104.60--124.98)     0.273
    Diastolic pressure (mmHg)                       57.68 (52.97--62.38)          57.32 (52.60--61.97)            59.78 (57.10--65.19)        0.036
    Respiratory rate (bpm)                          17.26 (14.96--19.27)          17.02 (14.94--19.21)            18.69 (16.13--21.00)        0.040
    Temperature (°C)                                37.64 (37.10--38.10)          37.67 (37.18--38.10)            37.25 (36.72--37.82)        0.041
    SpO2 (%)                                        93.00 (91.00--95.00)          93.00 (91.00--95.00)            92.00 (86.75--94.00)        0.023
  Urine output in first day (ml)                    1,670.00 (981.00--2,580.00)   1,730.00 (1,071.50--2,602.50)   450.00 (246.25--1,342.00)   \<0.001
  RTT in first day                                  5 (1.83%)                     2 (0.80%)                       3 (12.50%)                  0.005
  Ventilation in first day                          227 (83.15%)                  205 (82.33%)                    22 (91.67%)                 0.390
  Sepsis (based on ICD-9 codes)                     8 (2.93%)                     4 (1.61%)                       4 (16.67%)                  0.003
  Sepsis (based on Angus criteria)                  78 (28.57%)                   63 (25.30%)                     15 (62.50%)                 \<0.001
  Lab examination                                                                                                                             
    WBC (K/ul)                                      12.50 (9.70--15.80)           12.10 (9.60--15.65)             14.75 (12.90--16.92)        0.025
    Platelet (K/ul)                                 147.50 (111.88--190.12)       151.00 (112.38--192.75)         132.00 (106.00--149.88)     0.027
    Hemoglobin (g/dl)                               9.00 (7.80--10.30)            9.25 (7.90--10.33)              8.20 (6.97--8.80)           0.002
    Creatinine (mg/dl)                              1.10 (0.80--1.60)             1.00 (0.80--1.50)               1.95 (1.45--2.20)           \<0.001
    BUN (mg/dl)                                     19.00 (15.00--26.00)          18.00 (15.00--25.00)            27.50 (21.75--35.75)        \<0.001
    Glucose (mg/dl)                                 172.00 (140.00--204.00)       171.00 (138.00--200.00)         215.00 (155.75--316.25)     0.005
    Lactate (mmol/l)                                3.15 (1.98--5.30)             2.80 (1.90--4.60)               7.00 (5.20--10.80)          \<0.001
    PTT (sec)                                       35.57 (30.54--42.75)          34.80 (30.16--42.21)            42.72 (36.30--65.26)        0.002
    INR                                             1.30 (1.20--1.50)             1.30 (1.16--1.45)               1.45 (1.20--1.77)           0.064
    PT (sec)                                        14.45 (13.40--15.85)          14.40 (13.35--15.64)            15.85 (13.45--17.35)        0.082
  Comorbidities                                                                                                                               
    Congestive heart failure                        11 (4.03%)                    10 (4.02%)                      1 (4.17%)                   1.000
    Cardiac arrhythmias                             12 (4.40%)                    11 (4.42%)                      1 (4.17%)                   1.000
    Valvular disease                                3 (1.10%)                     2 (0.80%)                       1 (4.17%)                   0.242
    Pulmonary circulation disorder                  2 (0.73%)                     2 (0.80%)                       0 (0.00%)                   1.000
    Peripheral vascular disorder                    71 (26.01%)                   64 (25.70%)                     7 (29.17%)                  0.808
    Hypertension                                    23 (8.42%)                    19 (7.63%)                      4 (16.67%)                  0.130
    Paralysis                                       7 (2.56%)                     6 (2.41%)                       1 (4.17%)                   0.479
    Other neurological disease                      4 (1.47%)                     2 (0.80%)                       2 (8.33%)                   0.040
    Chronic pulmonary disease                       79 (28.94%)                   72 (28.92%)                     7 (29.17%)                  1.000
    Uncomplicated diabetes                          41 (15.02%)                   39 (15.66%)                     2 (8.33%)                   0.549
    Complicated diabetes                            4 (1.47%)                     4 (1.61%)                       0 (0.00%)                   1.000
    Hypothyroidism                                  26 (9.52%)                    23 (9.24%)                      3 (12.50%)                  0.487
    Renal failure                                   31 (11.36%)                   26 (10.44%)                     5 (20.83%)                  0.167
    Liver disease                                   8 (2.93%)                     6 (2.41%)                       2 (8.33%)                   0.150
    Lymphoma                                        3 (1.10%)                     3 (1.20%)                       0 (0.00%)                   1.000
    Metastatic cancer                               2 (0.73%)                     2 (0.80%)                       0 (0.00%)                   1.000
    Solid tumor                                     4 (1.47%)                     4 (1.61%)                       0 (0.00%)                   1.000
    Rheumatoid arthritis                            8 (2.93%)                     7 (2.81%)                       1 (4.17%)                   0.526
    Coagulopathy                                    47 (17.22%)                   39 (15.66%)                     8 (33.33%)                  0.043
    Obesity                                         21 (7.69%)                    21 (8.43%)                      0 (0.00%)                   0.233
    Weight loss                                     7 (2.56%)                     7 (2.81%)                       0 (0.00%)                   1.000
    Fluid and electrolyte disorders                 76 (27.84%)                   67 (26.91%)                     9 (37.50%)                  0.339
    Blood loss anemia                               5 (1.83%)                     4 (1.61%)                       1 (4.17%)                   0.371
    Deficiency anemias                              35 (12.82%)                   34 (13.65%)                     1 (4.17%)                   0.333
    Alcohol abuse                                   8 (2.93%)                     8 (3.21%)                       0 (0.00%)                   1.000
    Psychoses                                       4 (1.47%)                     3 (1.20%)                       1 (4.17%)                   0.309
    Depression                                      12 (4.40%)                    12 (4.82%)                      0 (0.00%)                   0.608

Data are expressed as median (interquartile range) or n (%). Kruskal Wallis and Chi-square (or Fisher\'s exact) tests were used to compare continuous and categorical variables of the two groups, respectively. Statistical significance (P\<0.05) is shown in bold. ICU, intensive care unit; SOFA, Sepsis-related Organ Failure Assessment; APACHE III, Acute Physiology and Chronic Health Evaluation III; RTT, renal replacement therapy; ICD-9, International Classification of Diseases, 9th Revision; WBC, white blood cell; BUN, blood urea nitrogen; PTT, partial thromboplastin time; INR, international normalised ratio; PT, prothrombin time.

###### 

Clinical characteristics of study subjects stratified by anion gap levels on ICU admission.

  Parameter                                         Tertile 1 (n=81)                Tertile 2 (n=61)                Tertile 3 (n=131)             P-value
  ------------------------------------------------- ------------------------------- ------------------------------- ----------------------------- ---------
  Age (years)                                       69.77 (60.37--79.58)            69.67 (63.65--78.14)            76.14 (70.24--82.05)          \<0.001
  Sex (male), n(%)                                  39 (48.15%)                     35 (57.38%)                     80 (61.07%)                   0.180
  Type of aortic aneurysm                                                                                                                         \<0.001
    Thoracic aneurysm without mention of rupture    45 (55.56%)                     31 (50.82%)                     33 (25.19%)                   
    Abdominal aneurysm (ruptured)                   5 (6.17%)                       7 (11.48%)                      36 (27.48%)                   
    Abdominal aneurysm without mention of rupture   31 (38.27%)                     23 (37.70%)                     62 (47.33%)                   
  Anion Gap (mEq/l)                                 10.00 (9.00--11.00)             13.00 (12.00--13.00)            16.00 (14.00--17.50)          \<0.001
  ICU mortality                                     1 (1.23%)                       2 (3.28%)                       21 (16.03%)                   \<0.001
  Hospital mortality                                2 (2.47%)                       3 (4.92%)                       22 (16.79%)                   \<0.001
  ICU length of stay (days)                         2.27 (1.33--4.10)               3.11 (1.44--8.55)               5.75 (2.20--12.60)            \<0.001
  Hospital length of stay (days)                    7.84 (5.46--12.28)              9.27 (6.26--14.63)              12.22 (6.54--20.45)           0.002
  Severity score                                                                                                                                  
    SOFA                                            5.00 (3.00--6.00)               4.00 (3.00--7.00)               6.00 (4.50--9.00)             \<0.001
    APACHE III                                      33.00 (24.00--44.00)            36.00 (27.00--46.00)            49.00 (36.00--64.00)          \<0.001
  Vital signs                                                                                                                                     
    Heartrate (bpm)                                 79.79 (72.67--86.79)            79.86 (73.07--87.19)            81.90 (73.75--91.75)          0.438
    Systolic pressure (mmHg)                        109.73 (105.03--118.55)         117.89 (108.29--124.83)         117.79 (107.62--128.83)       0.002
    Diastolic pressure (mmHg)                       56.74 (52.82--61.74)            57.59 (53.28--62.43)            58.61 (53.25--63.48)          0.508
    Respiratory rate (bpm)                          16.36 (14.63--18.54)            17.31 (15.22--18.58)            18.08 (15.21--19.91)          0.029
    Temperature (°C)                                37.82 (37.40--38.18)            37.60 (37.03--38.00)            37.60 (37.03--38.06)          0.115
    SpO2 (%)                                        93.00 (91.00--95.00)            93.00 (91.00--95.00)            93.00 (91.00--95.00)          0.357
  Urine output in first day (ml)                    2,200.00 (1,605.00--2,730.00)   1,670.00 (1,087.00--2,515.00)   1,172.00 (650.00--2,229.50)   \<0.001
  RTT in first day                                  0 (0.00%)                       0 (0.00%)                       5 (3.82%)                     0.085
  Ventilation in first day                          71 (87.65%)                     53 (86.89%)                     103 (78.63%)                  0.158
  Sepsis (based on ICD-9 codes)                     2 (2.47%)                       0 (0.00%)                       6 (4.58%)                     0.257
  Sepsis (based on Angus criteria)                  11 (13.58%)                     15 (24.59%)                     52 (39.69%)                   \<0.001
  Lab examination                                                                                                                                 
    WBC (K/ul)                                      13.00 (9.70--15.60)             11.90 (10.10--13.83)            12.10 (9.22--16.67)           0.647
    Platelet (K/ul)                                 153.50 (121.00--190.00)         151.00 (108.00--184.00)         137.50 (108.88--194.00)       0.747
    Hemoglobin (g/dl)                               8.90 (7.90--10.00)              9.30 (7.70--10.30)              9.25 (7.82--10.28)            0.612
    Creatinine (mg/dl)                              0.80 (0.70--1.10)               1.00 (0.80--1.30)               1.40 (1.00--1.95)             \<0.001
    BUN (mg/dl)                                     16.00 (13.00--19.00)            17.00 (15.00--21.00)            24.00 (18.00--30.00)          \<0.001
    Glucose (mg/dl)                                 160.00 (138.00--180.00)         162.00 (139.00--191.00)         185.00 (153.00--236.00)       \<0.001
    Lactate (mmol/l)                                2.50 (2.00--3.90)               3.15 (2.03--4.85)               3.60 (1.95--6.65)             0.034
    PTT (sec)                                       35.42 (31.22--41.99)            34.55 (30.40--41.95)            36.80 (30.57--44.38)          0.702
    INR                                             1.30 (1.20--1.45)               1.30 (1.15--1.40)               1.30 (1.20--1.60)             0.371
    PT (sec)                                        14.50 (13.62--15.53)            14.35 (13.20--15.22)            14.55 (13.26--16.04)          0.596

Data are expressed as median (interquartile range) or n (%). Kruskal Wallis and Chi-square (or Fisher\'s exact) tests were used to analyze continuous and categorical variables, respectively. Statistical significance (P\<0.05) is shown in bold. ICU, intensive care unit; SOFA, Sepsis-related Organ Failure Assessment; APACHE III, Acute Physiology and Chronic Health Evaluation III; RTT, renal replacement therapy; ICD-9, International Classification of Diseases, 9th Revision; WBC, white blood cell; BUN, blood urea nitrogen; PTT, partial thromboplastin time; INR, international normalised ratio; PT, prothrombin time.

###### 

Threshold effect analysis of anion gap on ICU mortality using piecewise linear regression.

  Inflection point of anion gap on ICU mortality (mEq/l)   β (95% CI)          ∆β (95% CI)         P-value   P for ∆β
  -------------------------------------------------------- ------------------- ------------------- --------- ----------
  \<17                                                     1.51 (1.12, 2.04)                       0.0074    
  \>17                                                     1.14 (0.97, 1.34)                       0.1148    
                                                                               0.76 (0.51--1.12)             0.1580

Adjusted for age, SOFA, and sex. ICU, intensive care unit; CI, confidence interval; SOFA, Sepsis-related Organ Failure Assessment.

###### 

Univariate analysis of intensive care unit mortality.

  Variable                                          OR (95% CI)            P-value
  ------------------------------------------------- ---------------------- ----------
  Age                                               1.07 (1.01, 1.12)      0.0116
  Sex                                                                      
    Male                                            1.0                    
    Female                                          1.59 (0.69, 3.70)      0.2772
  Type of aortic aneurysm                                                  
    Thoracic aneurysm without mention of rupture    1.0                    
    Abdominal aneurysm (ruptured)                   6.18 (2.01, 18.98)     0.0015
    Abdominal aneurysm without mention of rupture   1.54 (0.49, 4.86)      0.4610
  Anion Gap (mEq/l)                                 1.36 (1.22, 1.52)      \<0.0001
  Severity score                                                           
    SOFA                                            1.46 (1.26, 1.69)      \<0.0001
    APSIII                                          1.05 (1.03, 1.07)      \<0.0001
  Vital signs                                                              
    Heartrate (bpm)                                 1.07 (1.03, 1.10)      0.0004
    Systolic pressure (mmHg)                        0.98 (0.95, 1.02)      0.3266
    Diastolic pressure (mmHg)                       1.04 (0.99, 1.10)      0.1182
    Respiratory rate (bpm)                          1.15 (1.02, 1.29)      0.0183
    Temperature (°C)                                0.59 (0.32, 1.09)      0.0909
    SpO2 (%)                                        0.97 (0.93, 1.01)      0.0993
  Urine output in first day (ml)                    1.00 (1.00, 1.00)      0.0014
  RTT in first day                                                         
    No                                              1.0                    
    Yes                                             17.64 (2.79, 111.52)   0.0023
  Ventilation in first day                                                 
    No                                              1.0                    
    Yes                                             2.36 (0.54, 10.41)     0.2564
  Sepsis (based on ICD-9 codes)                                            
    No                                              1.0                    
    Yes                                             12.25 (2.85, 52.69)    0.0008
  Sepsis (based on Angus criteria)                                         
    No                                              1.0                    
    Yes                                             4.92 (2.05, 11.8)      0.0004
  Lab examination                                                          
    White blood cell (K/ul)                         1.05 (0.98, 1.13)      0.1357

###### 

Univariate analysis of ICU mortality.

  Variable                            OR (95% CI)           P-value
  ----------------------------------- --------------------- ----------
    Platelet (K/ul)                   0.99 (0.98, 1.00)     0.0248
    Hemoglobin (g/dl)                 0.71 (0.56, 0.89)     0.0035
    Creatinine (mg/dl)                2.00 (1.39, 2.90)     0.0002
    Blood urea nitrogen (mg/dl)       1.06 (1.03, 1.10)     0.0003
    Glucose (mg/dl)                   1.01 (1.00, 1.01)     0.0005
    Lactate (mmol/l)                  1.41 (1.22, 1.61)     \<0.0001
    PTT (sec)                         1.03 (1.01, 1.05)     0.0017
    INR                               3.24 (1.30, 8.1)      0.0116
    Prothrombin time (sec)            1.08 (1.01, 1.16)     0.0270
  Comorbidities                                             
    Congestive heart failure                                0.9714
      No                              1.0                   
      Yes                             1.04 (0.13, 8.48)     
    Cardiac arrhythmias                                     0.9543
      No                              1.0                   
      Yes                             0.94 (0.12, 7.62)     
    Valvular disease                                        0.1767
      No                              1.0                   
      Yes                             5.37 (0.47, 61.50)    
    Pulmonary circulation disorder                          0.9897
      No                              1.0                   
      Yes                             0.00 (0.00, Inf)      
    Peripheral vascular disorder                            0.7121
      No                              1.0                   
      Yes                             1.19 (0.47, 3.00)     
    Hypertension                                            0.1389
      No                              1.0                   
      Yes                             2.42 (0.75, 7.81)     
    Paralysis                                               0.6076
      No                              1.0                   
      Yes                             1.76 (0.20, 15.27)    
    Other neurological disease                              0.0182
      No                              1.0                   
      Yes                             11.23 (1.51, 83.62)   
    Chronic pulmonary disease                               0.9793
      No                              1.0                   
      Yes                             1.01 (0.40, 2.54)     
    Uncomplicated diabetes                                  0.3465
      No                              1.0                   
      Yes                             0.49 (0.11, 2.17)     
    Complicated diabetes                                    0.9905
      No                              1.0                   
      Yes                             0.00 (0.00, Inf)      
    Hypothyroidism                                          0.6046
      No                              1.0                   
      Yes                             1.40 (0.39, 5.07)     
    Renal failure                                           0.1343
      No                              1.0                   
      Yes                             2.26 (0.78, 6.55)     
    Liver disease                                           0.1235
      No                              1.0                   
      Yes                             3.68 (0.70, 19.34)    
    Lymphoma                                                
      No                              1.0                   
      Yes                             0.00 (0.00, Inf)      0.9918
    Metastatic cancer                                       
      No                              1.0                   
      Yes                             0.00 (0.00, Inf)      0.9897
    Solid tumor                                             
      No                              1.0                   
      Yes                             0.00 (0.00, Inf)      0.9905
    Rheumatoid arthritis                                    
      No                              1.0                   
      Yes                             1.50 (0.18, 12.76)    0.7088
    Coagulopathy                                            
      No                              1.0                   
      Yes                             2.69 (1.08, 6.72)     0.0339
    Obesity                                                 
      No                              1.0                   
      Yes                             0.00 (0.00, Inf)      0.9909
    Weight loss                                             
      No                              1.0                   
      Yes                             0.00 (0.00, Inf)      0.9875
    Fluid and electrolyte disorders                         
      No                              1.0                   
      Yes                             1.63 (0.68, 3.90)     0.2725
    Blood loss anemia                                       
      No                              1.0                   
      Yes                             2.66 (0.29, 24.83)    0.3899
    Deficiency anemias                                      
      No                              1.0                   
      Yes                             0.27 (0.04, 2.10)     0.2135
    Alcohol abuse                                           
      No                              1.0                   
      Yes                             0.00 (0.00, Inf)      0.9913
    Psychoses                                               
      No                              1.0                   
      Yes                             3.57 (0.36, 35.67)    0.2793
    Depression                                              
      No                              1.0                   
      Yes                             0.00 (0.00, Inf)      0.9893

Statistical significance (P\<0.05) is shown in bold. OR, odds ratio; CI, confidence interval; SOFA, Sepsis-related Organ Failure Assessment; APACHE III, Acute Physiology and Chronic Health Evaluation III; RTT, renal replacement therapy; ICD-9, International Classification of Diseases, 9th Revision; PTT, partial thromboplastin time; INR, international normalised ratio.

###### 

Multivariate logistic regression for effects of anion gap on intensive care unit mortality.

  Variable       Odds ratio   95% confidence interval   P-value
  -------------- ------------ ------------------------- ----------
  Non-adjusted   1.36         1.22--1.52                \<0.0001
  Model I        1.26         1.11--1.42                0.0003
  Model II       1.38         1.08--1.76                0.0088

Model I, adjusted for age, sex, and SOFA. Model II, adjusted for type of aortic aneurysm, age, SOFA, blood urea nitrogen, heartrate, international normalised ratio, platelet, prothrombin time, PTT, respiratory rate, RTT in first day, urine output in first day, coagulopathy, hemoglobin, other neurological disease, glucose, sepsis (based on ICD-9 codes), and creatinine. Statistical significance (P\<0.05) is shown in bold. SOFA, Sepsis-related Organ Failure Assessment; PTT, partial thromboplastin time; RTT, renal replacement therapy; ICD-9, International Classification of Diseases, 9th Revision.

###### 

Subgroup analysis of associations between anion gap and intensive care unit mortality.

  Variable                                          n     OR     95% CI Low   95% CI High   P-value   P-value (interaction)
  ------------------------------------------------- ----- ------ ------------ ------------- --------- -----------------------
  Type of aortic aneurysm                                                                             0.1361
    Thoracic aneurysm without mention of rupture    109   1.22   0.98         1.53          0.0781    
    Abdominal aneurysm (ruptured)                   48    1.25   1.00         1.57          0.0464    
    Abdominal aneurysm without mention of rupture   116   2.02   1.19         3.42          0.0087    
  Sepsis (based on Angus criteria)                                                                    0.8300
    No                                              195   1.29   1.07         1.55          0.0069    
    Yes                                             78    1.25   1.03         1.52          0.0216    
  Coagulopathy                                                                                        0.2672
    No                                              226   1.39   1.15         1.67          0.0006    
    Yes                                             47    1.19   0.98         1.44          0.0814    
  Hemoglobin                                                                                          0.0134
    Low                                             91    1.13   0.99         1.28          0.0727    
    Middle                                          86    1.94   1.20         3.13          0.0065    
    High                                            95    1.53   1.00         2.35          0.0522    
  Fluid and electrolyte disorders                                                                     0.9546
    No                                              197   1.27   1.09         1.49          0.0022    
    Yes                                             76    1.26   1.04         1.54          0.0197    

Adjusted for: Age, sex and SOFA. Statistical significance (P\<0.05) is shown in bold. OR, odds ratio; CI, confidence interval.

###### 

Multivariate logistic regression for effects of anion gap on ICU mortality using imputed datasets.

  Variable         OR     95% CI       P-value
  ---------------- ------ ------------ ----------
  Dataset 1                            
    Non-adjusted   1.36   1.22--1.52   \<0.0001
    Model I        1.26   1.11--1.42   0.0003
    Model II       1.26   1.01--1.59   0.0440
  Dataset 2                            
    Non-adjusted   1.36   1.22--1.52   \<0.0001
    Model I        1.26   1.11--1.42   0.0003
    Model II       1.35   1.06--1.71   0.0141
  Dataset 3                            
    Non-adjusted   1.36   1.22--1.52   \<0.0001
    Model I        1.26   1.11--1.42   0.0003
    Model II       1.36   1.07--1.74   0.0125
  Dataset 4                            
    Non-adjusted   1.36   1.22--1.52   \<0.0001
    Model I        1.26   1.11--1.42   0.0003
    Model II       1.39   1.10--1.76   0.0052
  Dataset 5                            
    Non-adjusted   1.36   1.22--1.52   \<0.0001
    Model I        1.26   1.11--1.42   0.0003
    Model II       1.44   1.12--1.84   0.0043
  Pooled                               
    Non-adjusted   1.36   1.22--1.52   \<0.0001
    Model I        1.26   1.11--1.43   0.0002
    Model II       1.36   1.05--1.76   0.0195

Model I, adjusted for age and SOFA. Model II, adjusted for type of aortic aneurysm, age, SOFA, BUN, heartrate, INR, platelet, PT, PTT, respiratory rate, RTT in first day, urine output in first day, hemoglobin, other neurological disease, glucose, sepsis (based on ICD-9 codes), creatinine, and lactate. Dataset 3--5 were adjusted for model II and coagulopathy. Statistical significance (P\<0.05) is shown in bold. OR, odds ratio; CI, confidence interval; ICU, intensive care unit; SOFA, Sepsis-related Organ Failure Assessment; BUN, blood urea nitrogen; INR, international normalised ratio; PT, prothrombin time; PTT, partial thromboplastin time; RTT, renal replacement therapy; ICD-9, International Classification of Diseases, 9th Revision.

###### 

Univariate analysis of ICU mortality after excluding patients with ruptured aortic aneurysm.

  Variable                                          OR (95% CI)            P-value
  ------------------------------------------------- ---------------------- ---------
  Age                                               1.07 (1.00, 1.14)      0.0523
  Sex                                                                      
    Male                                            1.0                    
    Female                                          3.36 (1.00, 11.27)     0.0494
  Type of aortic aneurysm                                                  
    Thoracic aneurysm without mention of rupture    1.0                    
    Abdominal aneurysm without mention of rupture   1.54 (0.49, 4.86)      0.4610
  Anion gap (mEq/l)                                 1.44 (1.19, 1.75)      0.0002
  Severity score                                                           
    SOFA                                            1.38 (1.16, 1.65)      0.0002
    APSIII                                          1.05 (1.02, 1.08)      0.0003
  Vital signs                                                              
    Heartrate (bpm)                                 1.06 (1.01, 1.10)      0.0161
    Systolic pressure (mmHg)                        0.98 (0.94, 1.03)      0.4983
    Diastolic pressure (mmHg)                       1.02 (0.95, 1.09)      0.5753
    Respiratory rate (bpm)                          1.12 (0.96, 1.31)      0.1427
    Temperature (°C)                                0.52 (0.23, 1.18)      0.1193
    SpO2 (%)                                        0.97 (0.93, 1.01)      0.1316
  Urine output in first day (ml)                    1.00 (1.00, 1.00)      0.1029
  RTT in first day                                                         
    No                                              1.0                    
    Yes                                             8.75 (0.74, 103.44)    0.0852
  Ventilation in first day                                                 
    No                                              1.0                    
    Yes                                             2.79 (0.35, 22.09)     0.3309
  Sepsis (based on ICD-9 codes)                                            
    No                                              1.0                    
    Yes                                             23.11 (4.96, 107.61)   0.0001
  Sepsis (based on angus criteria)                                         
    No                                              1.0                    
    Yes                                             5.62 (1.75, 17.98)     0.0036
  Lab examination                                                          
    WBC (K/ul)                                      1.04 (0.94, 1.14)      0.4594
    Platelet (K/ul)                                 0.99 (0.98, 1.00)      0.0758
    Hemoglobin (g/dl)                               0.70 (0.50, 0.98)      0.0398
    Creatinine (mg/dl)                              1.66 (1.05, 2.64)      0.0310
    BUN (mg/dl)                                     1.06 (1.01, 1.10)      0.0106
    Glucose (mg/dl)                                 1.01 (1.00, 1.01)      0.0585
    Lactate (mmol/l)                                1.53 (1.21, 1.93)      0.0004
    PTT (sec)                                       1.02 (0.99, 1.05)      0.1386
    INR                                             1.43 (0.26, 7.73)      0.6795
    PT (sec)                                        0.95 (0.72, 1.27)      0.7441
  Comorbidities                                                            
    Congestive heart failure                                               
      No                                            1.0                    
      Yes                                           2.44 (0.28, 21.47)     0.4213
    Cardiac arrhythmias                                                    
      No                                            1.0                    
      Yes                                           2.12 (0.25, 18.41)     0.4938
    Valvular disease                                                       
      No                                            1.0                    
      Yes                                           8.75 (0.74, 103.44)    0.0852
    Pulmonary circulation disorder                                         
      No                                            1.0                    
      Yes                                           0.00 (0.00, Inf)       0.9935
    Peripheral vascular disorder                                           
      No                                            1.0                    
      Yes                                           1.92 (0.60, 6.14)      0.2693
    Hypertension                                                           
      No                                            1.0                    
      Yes                                           3.67 (0.92, 14.71)     0.0659
    Paralysis                                                              
      No                                            1.0                    
      Yes                                           0.00 (0.00, Inf)       0.9908
    Other neurological disease                                             
      No                                            1.0                    
      Yes                                           17.58 (1.04, 298.62)   0.0473
    Chronic pulmonary disease                                              
      No                                            1.0                    
      Yes                                           1.51 (0.48, 4.80)      0.4832
    Uncomplicated diabetes                                                 
      No                                            1.0                    
      Yes                                           0.45 (0.06, 3.59)      0.4529
    Complicated diabetes                                                   
      No                                            1.0                    
      Yes                                           0.00 (0.00, Inf)       0.9908
    Hypothyroidism                                                         
      No                                            1.0                    
      Yes                                           1.85 (0.38, 8.95)      0.4462
    Renal failure                                                          
      No                                            1.0                    
      Yes                                           2.59 (0.66, 10.13)     0.1712
    Liver disease                                                          
      No                                            1.0                    
      Yes                                           3.45 (0.37, 31.91)     0.2752
    Lymphoma                                                               
      No                                            1.0                    
      Yes                                           0.00 (0.00, Inf)       0.9921
    Metastatic cancer                                                      
      No                                            1.0                    
      Yes                                           0.00 (0.00, Inf)       0.9930
    Solid tumor                                                            
      No                                            1.0                    
      Yes                                           0.00 (0.00, Inf)       0.9908
    Rheumatoid arthritis                                                   
      No                                            1.0                    
      Yes                                           2.44 (0.28, 21.47)     0.4213
    Coagulopathy                                                           
      No                                            1.0                    
      Yes                                           2.80 (0.81, 9.7)       0.1034
    Obesity                                                                
      No                                            1.0                    
      Yes                                           0.00 (0.00, Inf)       0.9913
    Weight loss                                                            
      No                                            1.0                    
      Yes                                           0.00 (0.00, Inf)       0.9921
    Fluid and electrolyte disorders                                        
      No                                            1.0                    
      Yes                                           0.97 (0.26, 3.67)      0.9666
    Blood loss anemia                                                      
      No                                            1.0                    
      Yes                                           0.00 (0.00, Inf)       0.9921
    Deficiency anemias                                                     
      No                                            1.0                    
      Yes                                           0.00 (0.00, Inf)       0.9895
    Alcohol abuse                                                          
      No                                            1.0                    
      Yes                                           0.00 (0.00, Inf)       0.9916
    Psychoses                                                              
      No                                            1.0                    
      Yes                                           8.75 (0.74, 103.44)    0.0852
    Depression                                                             
      No                                            1.0                    
      Yes                                           0.00 (0.00, Inf)       0.9901

Statistical significance (P\<0.05) is shown in bold. ICU, intensive care unit; OR, odds ratio; CI, confidence interval; SOFA, Sepsis-related Organ Failure Assessment; APACHE III, Acute Physiology and Chronic Health Evaluation III; RTT, renal replacement therapy; ICD-9, International Classification of Diseases, 9th Revision; WBC, white blood cell; BUN, blood urea nitrogen; PTT, partial thromboplastin time; INR, international normalised ratio; PT, prothrombin time.

###### 

Multivariate logistic regression for effects of anion gap on ICU mortality after excluding patients with ruptured aortic aneurysm.

  Variable       OR     95% CI       P-value
  -------------- ------ ------------ ---------
  Non-adjusted   1.44   1.19--1.75   0.0002
  Model I        1.33   1.08--1.62   0.0064
  Model II       1.46   1.09--1.97   0.0112

Model I, adjusted for age, sex, and SOFA. Model II, adjusted for sex, SOFA, BUN, heartrate, hemoglobin, sepsis (based on ICD-9 codes), other neurological disease, and creatinine. Statistical significance (P\<0.05) is shown in bold. ICU, intensive care unit; OR, odds ratio; CI, confidence interval.
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